Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (431-440 of 456) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2022
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
The British Journal of Surgery|May 3, 2023
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanomaLuca G Campana, Sofia Farronato, Jackie Hodgetts, et al.
The Lancet. Oncology|April 15, 2021
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialAndrew Bottomley, Corneel Coens, Justyna Mierzynska, et al.
Annals of Surgical Oncology|March 19, 2021
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working GroupSanjay P Bagaria, Carol Swallow, Harini Suraweera, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapySarah K Jacques, Janet McKeown, Piyush Grover, et al.
Nature Cancer|December 27, 2021
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanismSusana García-Silva, Alberto Benito-Martín, Laura Nogués, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 24, 2025
Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborationsPawel Kalinski, Kathleen M Kokolus, Indu Ahluwalia, et al.
Pageof 46

Showing results (431-440 of 456) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2022
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective StudyBruno Vincenzi, Andrea Napolitano, Marta Fiocco, et al.
The British Journal of Surgery|May 3, 2023
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanomaLuca G Campana, Sofia Farronato, Jackie Hodgetts, et al.
The Lancet. Oncology|April 15, 2021
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialAndrew Bottomley, Corneel Coens, Justyna Mierzynska, et al.
Annals of Surgical Oncology|March 19, 2021
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working GroupSanjay P Bagaria, Carol Swallow, Harini Suraweera, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapySarah K Jacques, Janet McKeown, Piyush Grover, et al.
Nature Cancer|December 27, 2021
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanismSusana García-Silva, Alberto Benito-Martín, Laura Nogués, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
JAMA Oncology|May 26, 2018
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesAnna Maria Frezza, Robin L Jones, Salvatore Lo Vullo, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 24, 2025
Meeting Highlights The 4th Marie Skłodowska-Curie Symposium on cancer research and care: Mechanisms of support for regional & international collaborationsPawel Kalinski, Kathleen M Kokolus, Indu Ahluwalia, et al.
Pageof 46